Table 4.

Incidence of Tumor Growth and Regression in Athymic Mice Injected With an LMP1-Transfected BL41 Cell Line

BL41 Cell Line LMP1 Status Tumors/ Mice Injected Days to Tumor Appearance Days to Tumor Regression Regressing Tumors % RegressionMaximum Size (cm2)
Parental  − 8/8  11 ± 4.7  —  0/8   0  —  
GTP  − 6/6  11 ± 7.1  57  1/6  17  7.2  
LMP1  6/6  20 ± 6.9  72 ± 24  4/6  67 4.4 ± 1.8  
GTP + LMP1  −/+  6/6  9.0 ± 3.3 50 ± 0.0  3/6  50  8.2 ± 0.9 
BL41 Cell Line LMP1 Status Tumors/ Mice Injected Days to Tumor Appearance Days to Tumor Regression Regressing Tumors % RegressionMaximum Size (cm2)
Parental  − 8/8  11 ± 4.7  —  0/8   0  —  
GTP  − 6/6  11 ± 7.1  57  1/6  17  7.2  
LMP1  6/6  20 ± 6.9  72 ± 24  4/6  67 4.4 ± 1.8  
GTP + LMP1  −/+  6/6  9.0 ± 3.3 50 ± 0.0  3/6  50  8.2 ± 0.9 

BL41 cells, vector only–transfected and LMP1-transfected BL41 cells (107) were inoculated subcutaneously into athymic BALB/c mice. A group of six mice was injected in the same subcutaneous site with equal numbers (107) of vector-transfected and LMP1-transfected BL41 cells. Experimental conditions and evaluation are described in the legend to Table 1.

Close Modal

or Create an Account

Close Modal
Close Modal